Skip to main content
. 2008 Jul 29;99(3):481–487. doi: 10.1038/sj.bjc.6604523

Figure 3.

Figure 3

Relative thymidine kinase (TK)-1 activity in MDA MB231 breast cancer cells after addition of (A) dCTP and (B) KIN52. Cells were exposed to IC50 concentrations of 5-fluorouracil (Inline graphic), doxorubicin (Inline graphic) and paclitaxel (▪), and compared with untreated cells (□). % cells are normalised to TK activity before addition of dCTP or KIN52 (set to 100%).